Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Imunon
AddedFeb 19, 2024
UpdatedJul 5, 2026
Imunon

Imunon

Public

IMUNON, Inc., a US-based clinical stage biotech company, innovates safe and effective treatments for a broad array of diseases.

HQ
Lawrenceville, NJ, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

IMUNON, Inc., formerly known as Celsion, was founded in Lawrenceville, New Jersey. The company is a clinical-stage biotechnology firm dedicated to developing innovative treatments that leverage the body's natural mechanisms to produce safe, effective, and lasting responses for a wide range of diseases. IMUNON focuses on creating proprietary immunology and DNA-based platforms and products, targeting some of the most challenging medical conditions. Their current projects include a Phase II clinical trial for ovarian cancer.

Notable figures associated with IMUNON include experienced scientists and industry leaders who have contributed to the company's research and development efforts. The company has attracted investment from reputable biotech investors, supporting its mission to advance groundbreaking medical treatments. IMUNON’s achievements include significant progress in clinical trials and the development of novel therapeutic platforms, positioning it as a promising player in the biotech industry with a potential for substantial impact on global health.

Imunon - Similar Companies

INmune Bio logo

INmune Bio

inmunebio.com

Immunome logo

Immunome

Cel-Sci logo

Cel-Sci

cel-sci.com

ImmunityBio logo

ImmunityBio

immunitybio.com

ImmuCision Biotherapeutics logo

ImmuCision Biotherapeutics

Immunaeon logo

Immunaeon

immunaeon.com

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

Inimmune logo

Inimmune

inimmune.com

Immunicom logo

Immunicom

immunicom.com

ImmunGene logo

ImmunGene

Nantkwest logo

Nantkwest

OmniCyte logo

OmniCyte

omnicyte.com

Cleveland BioLabs logo

Cleveland BioLabs

Imvax logo

Imvax

imvax.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Imunon - Quick Facts

Who are Imunon's competitors?

Companies similar to Imunon include INmune Bio, Immunome, Cel-Sci and ImmunityBio.

When was Imunon founded?

Imunon was founded in 2000.

Where is Imunon's headquarters located?

Imunon's headquarters is located in Lawrenceville, NJ, US.

When was Imunon's last funding round?

Imunon's most recent funding round was for $30M (USD) in January 2022.

How much has Imunon raised to-date?

As of Jan 10, 2022, Imunon has raised a total of $113.8M (USD).

How many employees does Imunon have?

Imunon has 27 employees as of Feb 6, 2024.

Imunon - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotech
  • Treatments
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0000749647
  • ticker: IMNN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334517Irradiation Apparatus Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3844X-ray Apparatus And Tubes And Related Irradiation Apparatus
  • 3845Electromedical And Electrotherapeutic Apparatus
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment